PMC7330645_01
Pelvic CT showed inflammation spread and abscess formation around the cecum (a). Abdominal CT showed a huge mass and multiple nodules in the liver (b). Chest CT showed nodules in the lungs (c). Arrows: lesions.
CRIONM2020-2351810.001.jpg
PMC7330645_01_CRIONM2020-2351810.001.jpg
fig1
Computed tomography (CT) scan of the abdomen and pelvis showed inflammation spread, abscess formation, lymphadenopathy around the cecum, and a huge mass with multiple nodules in the liver (Figures 1(a) and 1(b)). A chest CT also revealed multiple pulmonary nodules (Figure 1(c)).
Abdominal and chest CT before the administration of S-1 (a, b). Stable disease after therapy (c, d). Arrows: lesions in the liver.
CRIONM2020-2351810.002.jpg
PMC7330645_01_CRIONM2020-2351810.002.jpg
fig2
Therefore, we readministered the 5-FU oral preparation S-1 (80 mg/m2, Days 1-28, 42-day cycle), which provided a 7-month SD period (Figure 2).
Abdominal and chest CT before the administration of panitumumab (a, b). Stable disease after therapy (c, d). Pulmonary metastasis was slightly reduced after panitumumab treatment. Arrows: lesions in the liver.
CRIONM2020-2351810.003.jpg
PMC7330645_01_CRIONM2020-2351810.003.jpg
fig3
The patient achieved SD on this regimen for 7.5 months (Figure 3).